Sign in to edit your profile (add interests, mentoring, photo, etc.)

    John Adamson

    TitleClinical Professor
    SchoolUniversity of California, San Diego
    DepartmentMedicine
    Address9500 Gilman Drive #9111-E
    CA La Jolla 92093
    Phone858-822-6276

       Overview 
       Overview
      Research Interests
      Dr. Adamson's long-time interests have been in the regulation of red cell production, and particularly the role of erythropoietin in that process.

      He helped organize the original clinical trials of recombinant human erythropoietin in treating the anemia of patients with chronic kidney disease and participated in the application of erythropoietin therapy to the other anemias, including chemotherapy-induced anemia in cancer patients.

      He was on the original advisory National Kidney Foundation's Dialysis Outcomes Quality Initiative (DOQI) group that developed guidelines for "best practices" in the use of erythropoietin in kidney-related anemia. "In 2011, he participated in the international effort to harmonize anemia management in patients with CKD as part of the Kidney Disease: Improving Global Outcomes (KDIGO) effort."

      In parallel, he has been invovled in studies of iron metabolism for many years and the role of iron supply to the erythron. He has been particularly interested in the alterations in iron metabolism that occur with acute and chronic inflammation and in the use of supplemental iron to enhance the marrow's response to erythropoietin therapy.

      Expanded interests include the mechanisms of anemia as part of the aging process and how to effectively manage the anemia.

      Education and Training
      BA - University of California, Berkeley - 1958
      MD - University of California, Los Angeles - 1962
      Internship and Residency - University of Washington - 1962-1964
      Fellowship - Senior Fellow In Hematology, University of Washington - 1964-1967


       ORNG Applications 
       Websites

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Young DC, Layre E, Pan SJ, Tapley A, Adamson J, Seshadri C, Wu Z, Buter J, Minnaard AJ, Coscolla M, Gagneux S, Copin R, Ernst JD, Bishai WR, Snider BB, Moody DB. In Vivo Biosynthesis of Terpene Nucleosides Provides Unique Chemical Markers of Mycobacterium tuberculosis Infection. Chem Biol. 2015 Apr 23; 22(4):516-26.
        View in: PubMed
      2. Adamson JW. Iron, erythropoietic stimulating agents, and anemia in cancer. Crit Rev Oncog. 2013; 18(5):471-83.
        View in: PubMed
      3. von Drygalski A, Adamson JW. Iron metabolism in man. JPEN J Parenter Enteral Nutr. 2013 Sep; 37(5):599-606.
        View in: PubMed
      4. von Drygalski A, Adamson JW. Ironing out fatigue. Blood. 2011 Sep 22; 118(12):3191-2.
        View in: PubMed
      5. Vassallo RR, Adamson JW, Gottschall JL, Snyder EL, Lee W, Houghton J, Elfath MD. In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma. Transfusion. 2010 Nov; 50(11):2376-85.
        View in: PubMed
      6. Carson JL, Adamson JW. Iron deficiency and heart disease: ironclad evidence? Hematology Am Soc Hematol Educ Program. 2010; 2010:348-50.
        View in: PubMed
      7. Adamson JW. Erythropoietic-stimulating agents: the cancer progression controversy and collateral damage to the blood supply. Transfusion. 2009 May; 49(5):824-6.
        View in: PubMed
      8. Adamson JW. Hyporesponsiveness to erythropoiesis stimulating agents in chronic kidney disease: the many faces of inflammation. Adv Chronic Kidney Dis. 2009 Mar; 16(2):76-82.
        View in: PubMed
      9. Adamson JW. Renal disease and anemia in the elderly. Semin Hematol. 2008 Oct; 45(4):235-41.
        View in: PubMed
      10. McCullough J, Kahn J, Adamson J, Anderlini P, Benjamin R, Confer D, Eapen M, Hirsch B, Kuter D, Lazarus E, Pamphilon D, Stroncek D, Sugarman J, Wilson R. Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues. Transfusion. 2008 Sep; 48(9):2008-25.
        View in: PubMed
      11. Adamson JW. New blood, old blood, or no blood? N Engl J Med. 2008 Mar 20; 358(12):1295-6.
        View in: PubMed
      12. Adamson JW. The anemia of inflammation/malignancy: mechanisms and management. Hematology Am Soc Hematol Educ Program. 2008; 159-65.
        View in: PubMed
      13. Aubuchon JP, Dumont LJ, Herschel L, Roger J, Beddard RL, Taylor HL, Whitley PH, Sawyer SL, Graminske S, Martinson K, Dora R, Heldke S, Adamson J, Rose LE. Automated collection of double red blood cell units with a variable-volume separation chamber. Transfusion. 2008 Jan; 48(1):147-52.
        View in: PubMed
      14. Dai X, Chen Y, Schuman J, Hua Z, Adamson JW, Wen R, Wang D. Distinct roles of phosphoinositide-3 kinase and phospholipase Cgamma2 in B-cell receptor-mediated signal transduction. Mol Cell Biol. 2006 Jan; 26(1):88-99.
        View in: PubMed
      15. von Drygalski A, Savatski L, Eastwood D, Klein J, Adamson JW. The rate of marrow recovery and extent of donor engraftment following transplantation of ex vivo-expanded bone marrow cells are independently influenced by the cytokines used for expansion. Stem Cells Dev. 2005 Oct; 14(5):564-75.
        View in: PubMed
      16. Hess JR, Kagen LR, van der Meer PF, Simon T, Cardigan R, Greenwalt TJ, AuBuchon JP, Brand A, Lockwood W, Zanella A, Adamson J, Snyder E, Taylor HL, Moroff G, Hogman C. Interlaboratory comparison of red-cell ATP, 2,3-diphosphoglycerate and haemolysis measurements. Vox Sang. 2005 Jul; 89(1):44-8.
        View in: PubMed
      17. Chen SY, Cressman S, Mao F, Shao H, Low DW, Beilan HS, Cagle EN, Carnevali M, Gueriguian V, Keogh PJ, Porter H, Stratton SM, Wiedeke MC, Savatski L, Adamson JW, Bozzini CE, Kung A, Kent SB, Bradburne JA, Kochendoerfer GG. Synthetic erythropoietic proteins: tuning biological performance by site-specific polymer attachment. Chem Biol. 2005 Mar; 12(3):371-83.
        View in: PubMed
      18. Collins AJ, Li S, Adamson JW, Gilbertson DT. Assessment of pure red cell aplasia in US dialysis patients: the limits of the Medicare data. Am J Kidney Dis. 2004 Mar; 43(3):464-70.
        View in: PubMed
      19. Von Drygalski A, Alespeiti G, Ren L, Adamson JW. Murine bone marrow cells cultured ex vivo in the presence of multiple cytokine combinations lose radioprotective and long-term engraftment potential. Stem Cells Dev. 2004 Feb; 13(1):101-11.
        View in: PubMed
      20. Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, Ning G, Kaestner KH, Rossi JM, Zaret KS, Duncan SA. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet. 2003 Jul; 34(3):292-6.
        View in: PubMed
      21. Kochendoerfer GG, Chen SY, Mao F, Cressman S, Traviglia S, Shao H, Hunter CL, Low DW, Cagle EN, Carnevali M, Gueriguian V, Keogh PJ, Porter H, Stratton SM, Wiedeke MC, Wilken J, Tang J, Levy JJ, Miranda LP, Crnogorac MM, Kalbag S, Botti P, Schindler-Horvat J, Savatski L, Adamson JW, Kung A, Kent SB, Bradburne JA. Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein. Science. 2003 Feb 7; 299(5608):884-7.
        View in: PubMed
      22. von Drygalski A, Adamson JW. Placental/umbilical cord blood (PCB) stem cells for transplantation: early clinical outcomes and the status of ex vivo expansion strategies. Keio J Med. 2000 Dec; 49(4):141-51.
        View in: PubMed
      23. Li C, Rodriguez M, Adamson JW, Banerjee D. Identification of a glialblastoma cell differentiation factor-related gene mRNA in human microvascular endothelial cells. Genomics. 2000 May 1; 65(3):243-52.
        View in: PubMed
      24. Banerjee D, Rodriguez M, Nag M, Adamson JW. Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity. Kidney Int. 2000 May; 57(5):1895-904.
        View in: PubMed
      25. Eschbach JW, Adamson JW. Iron overload in renal failure patients: changes since the introduction of erythropoietin therapy. Kidney Int Suppl. 1999 Mar; 69:S35-43.
        View in: PubMed
      26. Adamson JW, Ludwig H. Predicting the hematopoietic response to recombinant human erythropoietin (Epoetin alfa) in the treatment of the anemia of cancer. Oncology. 1999; 56(1):46-53.
        View in: PubMed
      27. Adamson JW, Eschbach JW. Erythropoietin for end-stage renal disease. N Engl J Med. 1998 Aug 27; 339(9):625-7.
        View in: PubMed
      28. Adamson JW. Epoetin alfa: into the new millennium. Semin Oncol. 1998 Jun; 25(3 Suppl 7):76-9.
        View in: PubMed
      29. Adamson J. Perisurgical use of epoetin alfa in orthopedic surgery patients. Semin Hematol. 1996 Apr; 33(2 Suppl 2):55-8; discussion 59.
        View in: PubMed
      30. Adamson J. Erythropoietin, iron metabolism, and red blood cell production. Semin Hematol. 1996 Apr; 33(2 Suppl 2):5-7; discussion 8-9.
        View in: PubMed
      31. Adamson J. Epoetin alfa as an adjunct to autologous blood donation in patients with a low hematocrit scheduled for elective orthopedic surgery. Semin Hematol. 1996 Apr; 33(2 Suppl 2):15-6; discussion 17.
        View in: PubMed
      32. Barron C, Migliaccio AR, Migliaccio G, Jiang Y, Adamson JW, Ottolenghi S. Alternatively spliced mRNAs encoding soluble isoforms of the erythropoietin receptor in murine cell lines and bone marrow. Gene. 1994 Sep 30; 147(2):263-8.
        View in: PubMed
      33. Adamson JW. The relationship of erythropoietin and iron metabolism to red blood cell production in humans. Semin Oncol. 1994 Apr; 21(2 Suppl 3):9-15.
        View in: PubMed
      34. Adamson JW, Spivak JL. Physiologic basis for the pharmacologic use of recombinant human erythropoietin in surgery and cancer treatment. Surgery. 1994 Jan; 115(1):7-15.
        View in: PubMed
      35. Migliaccio AR, Jiang Y, Migliaccio G, Nicolis S, Crotta S, Ronchi A, Ottolenghi S, Adamson JW. Transcriptional and posttranscriptional regulation of the expression of the erythropoietin receptor gene in human erythropoietin-responsive cell lines. Blood. 1993 Dec 15; 82(12):3760-9.
        View in: PubMed
      36. Mercuriali F, Adamson JW. Recombinant human erythropoietin enhances blood donation for autologous use and reduces exposure to homologous blood during elective surgery. Semin Hematol. 1993 Oct; 30(4 Suppl 6):17-21.
        View in: PubMed
      37. Nicolis S, Ottolenghi S, Papayannopoulou T, Baiocchi M, Migliaccio G, Adamson J, Migliaccio AR. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7. Exp Hematol. 1993 May; 21(5):665-70.
        View in: PubMed
      38. Eschbach JW, Haley NR, Egrie JC, Adamson JW. A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects. Kidney Int. 1992 Aug; 42(2):407-16.
        View in: PubMed
      39. Adamson JW. Management of anemia in oncology. Introduction. Semin Oncol. 1992 Jun; 19(3 Suppl 8):1-2.
        View in: PubMed
      40. Migliaccio G, Migliaccio AR, Druzin ML, Giardina PJ, Zsebo KM, Adamson JW. Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor. Blood. 1992 May 15; 79(10):2620-7.
        View in: PubMed
      41. Shimada Y, Migliaccio G, Ruscetti S, Adamson JW, Migliaccio AR. Expression of the interleukin-3 and granulocyte-macrophage colony-stimulating factor genes in Friend spleen focus-forming virus-induced erythroleukemia. Blood. 1992 May 1; 79(9):2423-31.
        View in: PubMed
      42. Adamson JW, Schuster M, Allen S, Haley NR. Effectiveness of recombinant human erythropoietin therapy in myelodysplastic syndromes. Acta Haematol. 1992; 87 Suppl 1:20-4.
        View in: PubMed
      43. Migliaccio AR, Migliaccio G, D'Andrea A, Baiocchi M, Crotta S, Nicolis S, Ottolenghi S, Adamson JW. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface. Proc Natl Acad Sci U S A. 1991 Dec 15; 88(24):11086-90.
        View in: PubMed
      44. Migliaccio G, Migliaccio AR, Valinsky J, Langley K, Zsebo K, Visser JW, Adamson JW. Stem cell factor induces proliferation and differentiation of highly enriched murine hematopoietic cells. Proc Natl Acad Sci U S A. 1991 Aug 15; 88(16):7420-4.
        View in: PubMed
      45. Adamson JW. Erythropoietin: its role in the regulation of erythropoiesis and as a therapeutic in humans. Biotechnology. 1991; 19:351-63.
        View in: PubMed
      46. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. The safety of epoetin-alpha: results of clinical trials in the United States. Contrib Nephrol. 1991; 88:72-80.
        View in: PubMed
      47. Buckner FS, Eschbach JW, Haley NR, Davidson RC, Adamson JW. Hypertension following erythropoietin therapy in anemic hemodialysis patients. Am J Hypertens. 1990 Dec; 3(12 Pt 1):947-55.
        View in: PubMed
      48. Robertson HT, Haley NR, Guthrie M, Cardenas D, Eschbach JW, Adamson JW. Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients. Am J Kidney Dis. 1990 Apr; 15(4):325-32.
        View in: PubMed
      49. Adamson JW, Eschbach JW. Treatment of the anemia of chronic renal failure with recombinant human erythropoietin. Annu Rev Med. 1990; 41:349-60.
        View in: PubMed
      50. Adamson JW, Eschbach JW. The use of recombinant human erythropoietin [rHuEpo] in man. Prog Clin Biol Res. 1990; 352:505-17.
        View in: PubMed
      51. Eschbach JW, Haley NR, Adamson JW. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin. Contrib Nephrol. 1990; 78:24-36; discussion 37.
        View in: PubMed
      52. Adamson JW, Eschbach JW. Management of the anaemia of chronic renal failure with recombinant erythropoietin. Q J Med. 1989 Dec; 73(272):1093-101.
        View in: PubMed
      53. Eschbach JW, Adamson JW. Guidelines for recombinant human erythropoietin therapy. Am J Kidney Dis. 1989 Aug; 14(2 Suppl 1):2-8.
        View in: PubMed
      54. Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med. 1989 Jul 20; 321(3):158-63.
        View in: PubMed
      55. Adamson JW. The promise of recombinant human erythropoietin. Semin Hematol. 1989 Apr; 26(2 Suppl 2):5-8.
        View in: PubMed
      56. Eschbach JW, Downing MR, Egrie JC, Browne JK, Adamson JW. USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients. Contrib Nephrol. 1989; 76:160-5; discussion 212-8.
        View in: PubMed
      57. Adamson JW. Erythropoietin: in vitro and in vivo studies of the regulation of erythropoiesis. Schweiz Med Wochenschr. 1988 Oct 22; 118(42):1501-6.
        View in: PubMed
      58. Broudy VC, Lin N, Egrie J, de Haën C, Weiss T, Papayannopoulou T, Adamson JW. Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxide. Proc Natl Acad Sci U S A. 1988 Sep; 85(17):6513-7.
        View in: PubMed
      59. Migliaccio G, Migliaccio AR, Adamson JW. In vitro differentiation of human granulocyte/macrophage and erythroid progenitors: comparative analysis of the influence of recombinant human erythropoietin, G-CSF, GM-CSF, and IL-3 in serum-supplemented and serum-deprived cultures. Blood. 1988 Jul; 72(1):248-56.
        View in: PubMed
      60. Segal GM, Eschbach JW, Egrie JC, Stueve T, Adamson JW. The anemia of end-stage renal disease: hematopoietic progenitor cell response. Kidney Int. 1988 May; 33(5):983-8.
        View in: PubMed
      61. Eschbach JW, Adamson JW. Recombinant human erythropoietin: implications for nephrology. Am J Kidney Dis. 1988 Mar; 11(3):203-9.
        View in: PubMed
      62. Adamson JW. Erythropoietin: in vitro and in vivo studies of the regulation of erythropoiesis. Soc Gen Physiol Ser. 1988; 43:57-65.
        View in: PubMed
      63. Abkowitz JL, Holly RD, Adamson JW. Retrovirus-induced feline pure red cell aplasia: the kinetics of erythroid marrow failure. J Cell Physiol. 1987 Sep; 132(3):571-7.
        View in: PubMed
      64. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med. 1987 Jan 8; 316(2):73-8.
        View in: PubMed
      65. Abkowitz JL, Ott RL, Holly RD, Adamson JW. Lymphocytes and antibody in retrovirus-induced feline pure red cell aplasia. J Natl Cancer Inst. 1987 Jan; 78(1):135-9.
        View in: PubMed
      66. Abkowitz JL, Powell JS, Nakamura JM, Kadin ME, Adamson JW. Pure red cell aplasia: response to therapy with anti-thymocyte globulin. Am J Hematol. 1986 Dec; 23(4):363-71.
        View in: PubMed
      67. Wardrop KJ, Kramer JW, Abkowitz JL, Clemons G, Adamson JW. Quantitative studies of erythropoiesis in the clinically normal, phlebotomized, and feline leukemia virus-infected cat. Am J Vet Res. 1986 Oct; 47(10):2274-7.
        View in: PubMed
      68. Abkowitz JL, Kadin ME, Powell JS, Adamson JW. Pure red cell aplasia: lymphocyte inhibition of erythropoiesis. Br J Haematol. 1986 May; 63(1):59-67.
        View in: PubMed
      69. Delwiche F, Segal GM, Eschbach JW, Adamson JW. Hematopoietic inhibitors in chronic renal failure: lack of in vitro specificity. Kidney Int. 1986 Mar; 29(3):641-8.
        View in: PubMed
      70. Eschbach JW, Adamson JW. Anemia of end-stage renal disease (ESRD). Kidney Int. 1985 Jul; 28(1):1-5.
        View in: PubMed
      71. Abkowitz JL, Ott RL, Nakamura JM, Steinmann L, Fialkow PJ, Adamson JW. Feline glucose-6-phosphate dehydrogenase cellular mosaicism. Application to the study of retrovirus-induced pure red cell aplasia. J Clin Invest. 1985 Jan; 75(1):133-40.
        View in: PubMed
      72. Eschbach JW, Mladenovic J, Garcia JF, Wahl PW, Adamson JW. The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo. J Clin Invest. 1984 Aug; 74(2):434-41.
        View in: PubMed
      73. Adamson JW. The polycythemias: diagnosis and treatment. Hosp Pract (Off Ed). 1983 Dec; 18(12):49-57.
        View in: PubMed
      74. Delwiche F, Garrity MJ, Powell JS, Robertson RP, Adamson JW. High levels of the circulating form of parathyroid hormone do not inhibit in vitro erythropoiesis. J Lab Clin Med. 1983 Oct; 102(4):613-20.
        View in: PubMed
      75. Hammond WP, Adamson JW, Dale DC. Canine cyclic haematopoiesis: the effect of endotoxin on erythropoiesis. Br J Haematol. 1982 Feb; 50(2):283-94.
        View in: PubMed
      76. Lindner A, Douglas SW, Adamson JW. Propranolol effects in long-term hemodialysis patients with renin-dependent hypertension. Ann Intern Med. 1978 Apr; 88(4):457-62.
        View in: PubMed
      77. Fisher JW, Adamson JW, Camiscoli JF, Fried W, Gordon AS, Schooley J, Zanjani E. Cooperative erythropoietic assay of several steroid metabolites in polycythemic mice. Steroids. 1977 Dec; 30(6):833-45.
        View in: PubMed
      78. Brown JE, Adamson JW. Modulation of in vitro erythropoiesis: enhancement of erythroid colony growth by cyclic nucleotides. Cell Tissue Kinet. 1977 May; 10(3):289-98.
        View in: PubMed
      79. Brown JE, Adamson JW. Studies of the influence of cyclic nucleotides on in vitro haemoglobin synthesis. Br J Haematol. 1977 Feb; 35(2):193-208.
        View in: PubMed
      80. Singer JW, Samuels AI, Adamson JW. Steroids and hematopoiesis. I. The effect of steroids on in vitro erythroid colony growth: structure/activity relationships. J Cell Physiol. 1976 Jun; 88(2):127-34.
        View in: PubMed
      81. Adamson JW. Familial polycythemia. Semin Hematol. 1975 Oct; 12(4):383-96.
        View in: PubMed
      82. Douglas SW, Adamson JW. The anemia of chronic disorders: studies of marrow regulation and iron metabolism. Blood. 1975 Jan; 45(1):55-65.
        View in: PubMed
      83. Adamson JW, Dale DC, Elin RJ. Hematopoiesis in the grey collie dog: studies of the regulation of erythropoiesis. J Clin Invest. 1974 Oct; 54(4):965-73.
        View in: PubMed
      84. Adamson JW, Stamatoyannopoulos G, Kontras S, Lascari A, Detter J. Recessive familial erythrocytosis: aspects of marrow regulation in two families. Blood. 1973 May; 41(5):641-52.
        View in: PubMed
      85. Eschbach JW, Adamson JW. Improvement in the anemia of chronic renal failure with fluoxymesterone. Ann Intern Med. 1973 Apr; 78(4):527-32.
        View in: PubMed
      86. Adamson JW, Hayashi A, Stamatoyannopoulos G, Burger WF. Erythrocyte function and marrow regulation in hemoglobin Bethesda (beta-145 histidine). J Clin Invest. 1972 Nov; 51(11):2883-8.
        View in: PubMed
      87. Eschbach JW, Adamson JW, Anderson RG, Dennis MB. Anemia of chronic renal failure: studies of marrow regulation in the uremic sheep. Trans Am Soc Artif Intern Organs. 1972; 18(0):295-300.
        View in: PubMed
      88. Adamson JW, Finch CA. Erythropoietin and the regulation of erythropoiesis in DiGuglielmo's syndrome. Blood. 1970 Nov; 36(5):590-7.
        View in: PubMed
      89. Eschbach JW, Adamson JW, Cook JD. Disorders of red blood cell production in uremia. Arch Intern Med. 1970 Nov; 126(5):812-5.
        View in: PubMed
      90. Adamson JW, Parer JT, Stamatoyannopoulos G. Erythrocytosis associated with hemoglobin Rainier: oxygen equilibria and marrow regulation. J Clin Invest. 1969 Aug; 48(8):1376-86.
        View in: PubMed
      91. Adamson JW. The erythropoietin-hematocrit relationship in normal and polycythemic man: implications of marrow regulation. Blood. 1968 Oct; 32(4):597-609.
        View in: PubMed
      92. Adamson JW, Eschbach J, Finch CA. The kidney and erythropoiesis. Am J Med. 1968 May; 44(5):725-33.
        View in: PubMed
      93. Hillman RS, Adamson J, Burka E. Characteristics of vitamin B12 correction of the abnormal erythropoiesis of pernicious anemia. Blood. 1968 Apr; 31(4):419-32.
        View in: PubMed
      94. Eschbach JW, Funk D, Adamson J, Kuhn I, Scribner BH, Finch CA. Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med. 1967 Mar 23; 276(12):653-8.
        View in: PubMed
      95. Adamson JW, Finch CA. Mechanisms of erythroid marrow activation. Trans Assoc Am Physicians. 1966; 79:419-25.
        View in: PubMed
      John's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Back to TOP